- Home
- DCBO vs CYRX Comparison
DCBO vs CYRX Comparison
Compare DCBO & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DCBO | CYRX |
|---|---|---|
| Founded | 2016 | 1999 |
| Country | Canada | United States |
| Employees | N/A | 1100 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.9M | 421.6M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | DCBO | CYRX |
|---|---|---|
| Price | $22.51 | $8.01 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 9 |
| Target Price | ★ $32.00 | $12.94 |
| AVG Volume (30 Days) | 261.2K | ★ 354.6K |
| Earning Date | 01-01-0001 | 06-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 156.22 |
| EPS | N/A | ★ 1.40 |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | $12.54 | $9.71 |
| Revenue Next Year | $11.82 | $9.56 |
| P/E Ratio | $22.04 | ★ $5.62 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $16.07 | $4.63 |
| 52 Week High | $33.69 | $11.45 |
Technical Indicators
Market Signals| Indicator | DCBO | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 69.81 | 38.62 |
| Support Level | $21.72 | $6.57 |
| Resistance Level | $23.16 | $8.45 |
| Average True Range (ATR) | 0.86 | 0.45 |
| MACD | 0.49 | 0.01 |
| Stochastic Oscillator | 100.00 | 23.71 |
Price Performance
Historical ComparisonAbout DCBO Docebo Inc.
Docebo Inc is a provider of cloud-based learning management systems. The solutions provided by the company allow learning administrators to deliver scalable and flexible personalized learning experiences, from formal training to social learning to multiple internal, external, and blended audiences. The group provides an easy-to-use, configurable, and affordable learning platform with the end-to-end capabilities and critical functionality needed to train both internal and external workforces, partners, and customers. The majority of the revenue is derived from customers based in North America.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.